Abstract
Access to the full range of contraceptive methods is a foundational component of reproductive well-being [1], and we are at a pivotal moment for contraceptive access in the United States. The Food and Drug Administration (FDA) is considering the first-ever application for an over-the-counter (OTC) progestin-only oral contraceptive pill—a culmination of more than two decades of science and advocacy that would put the U.S. on par with many other countries where oral contraception has long been available OTC [2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
